Rubella

Common Name(s)

Rubella

Rubella is a contagious infection that occurs most often in children and young adults. Symptoms of the disease include rash, low fever, nausea, swollen lymph glands behind the ears and in the neck, and mild pink eye. In adults, symptoms may also include arthritis and painful joints. While rubella is generally mild in children, it can have serious consequences in pregnant women. Pregnant women who are infected early in pregnancy have a 90% chance of passing the virus onto the fetus, which can cause miscarriage, stillbirth, fetal death, or severe birth defects known as congenital rubella syndrome. Rubella is preventable by vaccination.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Rubella" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Rubella" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Rubella" returned 1353 free, full-text research articles on human participants. First 3 results:

Sentinel Surveillance for Congenital Rubella Syndrome - India, 2016-2017.
 

Author(s): Manoj Murhekar, Ashish Bavdekar, Asha Benakappa, Sridhar Santhanam, Kuldeep Singh, Sanjay Verma, Gajanan N Sapkal, Nivedita Gupta, Valsan Philip Verghese, Rajlakshmi Viswanathan, Asha Mary Abraham, Shyama Choudhary, Gururajrao N Deshpande, Suji George, Garima Goyal, Parul Chawla Gupta, Ishani Jhamb, Deepa John, Swetha Philip, Sandeep Kadam, Ravinder Kaur Sachdeva, Praveen Kumar, Anjali Lepcha, S Mahantesh, S Manasa, Urvashi Nehra, Sanjay Kumar Munjal, Vijaya Lakshmi Nag, Sadanand Naik, Naga Raj, Jagat Ram, R K Ratho, C G Raut, Manoj Kumar Rohit, R Sabarinathan, Sanjay Shah, Pratibha Singh, Mini P Singh, Ashish Tiwari, Neelam Vaid

Journal:

 

Rubella infection during pregnancy can result in miscarriage, fetal death, stillbirth, or a constellation of congenital malformations known as congenital rubella syndrome (CRS). The 11 countries in the World Health Organization (WHO) South-East Asia Region are committed to the elimination ...

Last Updated: 31 Dec 1969

Go To URL
Diagnosis of rubella virus using antigen-conjugated Au@Pt nanorods as nanozyme probe.
 

Author(s): Tao Zhang, Fang Tian, Lin Long, Jianbo Liu, Xiaochun Wu

Journal:

 

As nanotechnology advances rapidly, the nanozymes which could replace protein enzymes in bioanalytical assays bring a new opportunity to the development of simple and sensitive diagnostic tools.

Last Updated: 31 Dec 1969

Go To URL
Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial.
 

Author(s):

Journal: Vaccine. 2018 09;36(38):5781-5788.

 

The potency of live viral vaccines decreases over time. We compared the immunogenicity and safety of GSK measles-mumps-rubella vaccine (MMR-RIT) formulations at two different potencies with that of the commercially-available MMR II formulation.

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Rubella" returned 57 free, full-text review articles on human participants. First 3 results:

A New Combined Vaccine Against Measles, Mumps, Rubella and Varicella in India.
 

Author(s): Nitin Shah, Raunak Parikh, Giacomo Casabona, Shafi Kolhapure

Journal: Indian Pediatr. 2017 12;54(12):1041-1046.

 

A quadrivalent MMRV (measles-mumps-rubella-varicella) combination vaccine has recently been launched in India. This vaccine is highly immunogenic, with seroconversion rates against all antigens reaching 96.6-100% at 42 to 56 days after the second vaccine dose in unvaccinated children ...

Last Updated: 31 Dec 1969

Go To URL
Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
 

Author(s): Walter A Orenstein, Lisa Cairns, Alan Hinman, Benjamin Nkowane, Jean-Marc Olivé, Arthur L Reingold

Journal: Vaccine. 2018 01;36 Suppl 1():A35-A42.

 

Measles, a vaccine-preventable illness, is one of the most infectious diseases known to man. In 2015, an estimated 134,200 measles deaths occurred globally. Rubella, also vaccine-preventable, is a concern because infection during pregnancy can result in congenital defects in the baby. ...

Last Updated: 31 Dec 1969

Go To URL
Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
 

Author(s): W A Orenstein, A Hinman, B Nkowane, J M Olive, A Reingold

Journal: Vaccine. 2018 01;36 Suppl 1():A1-A34.

 

1. Measles eradication is the ultimate goal but it is premature to set a date for its accomplishment. Existing regional elimination goals should be vigorously pursued to enable setting a global target by 2020. 2. The basic strategic approaches articulated in the Global Measles and ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 9 May 2017

Go to URL
Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age
 

Status: Not yet recruiting

Condition Summary: Measles; Rubella; Rubella Syndrome, Congenital

 

Last Updated: 1 Mar 2017

Go to URL
Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines
 

Status: Recruiting

Condition Summary: Vaccine Response Impaired

 

Last Updated: 7 Dec 2017

Go to URL